Global Controlled Release Cannabis Pills Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Controlled Release Cannabis Pills Market Research Report 2024
Cannabis is a psychoactive drug extracted from a genus of flowering plant of Cannabaceae family. It is also called as, marijuana. Over the last few decades use of cannabis for the medical purpose has increased and is described as medical marijuana. Increasing research in this area has suggested that it can be prescribed to treat a number of health conditions such as, chronic pain, insomnia, muscle spasm, and reduce nausea and vomiting during chemotherapy among other health conditions. Companies are increasingly investing on the research in the field of medical marijuana or cannabis. These research has led to the development of controlled release cannabis pills that can provide long lasting effect.
According to Mr Accuracy reports’s new survey, global Controlled Release Cannabis Pills market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Controlled Release Cannabis Pills market research.
Controlled release cannabis pills market is expected to show a significant growth over the forecast period owning to the increasing adoption of controlled release cannabis pills or capsule among people and prescribers as these drugs has lower side effects and can be used without much of the concern of feeling of unease. Long lasting effect of controlled release cannabis pills and increasing number of government legalizing distribution of medical marijuana is also expected to fuel the growth of controlled release cannabis pills market. Even though number of government legalizing the medical marijuana is increasing but regulatory bodies are posing as a restraint for the growth of controlled release cannabis pill market as they cannot legalize the use of narcotic substances under federal law.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Controlled Release Cannabis Pills market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cannabics Pharmaceuticals
Wana Edibles
Intec Pharma
Segment by Type
High THC Capsule
THC/CBD Balanced Capsules
High CBD Capsules
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Controlled Release Cannabis Pills report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Controlled Release Cannabis Pills market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Controlled Release Cannabis Pills market research.
Controlled release cannabis pills market is expected to show a significant growth over the forecast period owning to the increasing adoption of controlled release cannabis pills or capsule among people and prescribers as these drugs has lower side effects and can be used without much of the concern of feeling of unease. Long lasting effect of controlled release cannabis pills and increasing number of government legalizing distribution of medical marijuana is also expected to fuel the growth of controlled release cannabis pills market. Even though number of government legalizing the medical marijuana is increasing but regulatory bodies are posing as a restraint for the growth of controlled release cannabis pill market as they cannot legalize the use of narcotic substances under federal law.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Controlled Release Cannabis Pills market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cannabics Pharmaceuticals
Wana Edibles
Intec Pharma
Segment by Type
High THC Capsule
THC/CBD Balanced Capsules
High CBD Capsules
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Controlled Release Cannabis Pills report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices